VTAK
Catheter Precision, Inc.
$1.05
-1.87%
$2.8M
No data for this timeframe.
Vol
Market Cap$2.8M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$315.00
Inst. Activity1 buys / 0 sells
SEC Reports3
Press Releases8
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001716621·Prev Close $1.07
Recent Activity
Jun 8, 2026
Press
Catheter Precision (VTAK) subsidiary Flyte acquired ~2.9 million shares of Volato Group (SOAR), representing a ~7.5% sta
Impact 3/10
Jun 8, 2026
announcement
Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)
VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment S
Jun 8, 2026
SEC
Catheter Precision (VTAK) entered into a Securities Purchase Agreement to purchase 2,941,176 shares of Volato Group (SOA
8-K — Impact 4/10
May 4, 2026
Press
Catheter Precision's Flyte subsidiary announced a hiring initiative and fleet expansion plans following Spirit Airlines'
Impact 2/10
Apr 21, 2026
SEC
Catheter Precision reported 2025 full-year revenue of $819K, a 95% YoY increase, but posted a net loss of $17.2M. The co
8-K — Impact 6/10
Mar 26, 2026
Insider
Arno Andrew was granted 40,000 shares
Director
Mar 26, 2026
Insider
JENKINS DAVID A was granted 40,000 shares
Chairman of the Board and CEO
Mar 26, 2026
Insider
COLOMBATTO MARTIN J was granted 40,000 shares
Director
Analyst Ratings
3Strong Buy
3Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
Press
3/10
Catheter Precision (VTAK) subsidiary Flyte acquired ~2.9 million shares of Volato Group (SOAR), representing a ~7.5% sta
Jun 8, 2026
NEUTRAL
8-K
4/10
Catheter Precision (VTAK) entered into a Securities Purchase Agreement to purchase 2,941,176 shares of Volato Group (SOA
Jun 8, 2026
MIXED
8-K
6/10
Catheter Precision reported 2025 full-year revenue of $819K, a 95% YoY increase, but posted a net loss of $17.2M. The co
Apr 21, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| Allworth Financial LP | $303.00 | — |
| HRT FINANCIAL LP | $11.00 | — |
| CITIGROUP INC | $1.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 26, 2026 | Arno Andrew | A | $0.00 |
| Mar 26, 2026 | JENKINS DAVID | A | $0.00 |
| Mar 26, 2026 | COLOMBATTO MARTIN | A | $0.00 |
| Mar 26, 2026 | Caruso James | A | $0.00 |
| Mar 26, 2026 | ANDERSON PHILIP | A | $0.00 |
3 institutional holders with $315.00 total value (11,577 shares) as of 2026-Q1. Top holders: Allworth, HRT, CITIGROUP.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | Allworth Financial LP | 300 | $303.00 | 96.2% | — |
| 2 | HRT FINANCIAL LP | 11,276 | $11.00 | 3.5% | — |
| 3 | CITIGROUP INC | 1 | $1.00 | 0.3% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | DOUBLED | 10 | 297 | +2870.0% | $544.00 | 2025-Q4 |
5 unique insiders with 5 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Arno Andrew | Director | AWARD | 40,000 | — | — |
| Mar 26, 2026 | JENKINS DAVID A | Chairman of the Board and CEO | AWARD | 40,000 | — | — |
| Mar 26, 2026 | COLOMBATTO MARTIN J | Director | AWARD | 40,000 | — | — |
| Mar 26, 2026 | Caruso James Joseph | Director | AWARD | 40,000 | — | — |
| Mar 26, 2026 | ANDERSON PHILIP J | Chief Financial Officer | AWARD | 40,000 | — | — |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 1 mixed, 1 neutral. Avg impact: 5.7/10.
NEUTRAL
8-K
4/10
Catheter Precision (VTAK) entered into a Securities Purchase Agreement to purchase 2,941,176 shares
Jun 8, 2026
MIXED
8-K
6/10
Catheter Precision reported 2025 full-year revenue of $819K, a 95% YoY increase, but posted a net lo
Apr 21, 2026
BEARISH
DEFA14A
7/10
Catheter Precision, Inc. (VTAK) is holding a special shareholder meeting to approve several proposal
Mar 23, 2026
NEUTRAL
3/10
Catheter Precision (VTAK) subsidiary Flyte acquired ~2.9 million shares of Volato Group (SOAR), repr
Jun 8, 2026
NEUTRAL
2/10
Catheter Precision's Flyte subsidiary announced a hiring initiative and fleet expansion plans follow
May 4, 2026
BULLISH
6/10
Catheter Precision, Inc. (VTAK) announced a Notice of Allowance from the USPTO for key patents cover
Apr 21, 2026
NEUTRAL
4/10
Catheter Precision, Inc. (VTAK) announced that its regional air mobility subsidiary Flyte is expandi
Apr 20, 2026
NEUTRAL
3/10
Catheter Precision, Inc. (VTAK) announced plans to attend the EHRA 2026 conference in Paris, where i
Apr 8, 2026
NEUTRAL
4/10
Catheter Precision announced that a clinical study on its LockeT device was accepted for publication
Apr 6, 2026
MIXED
6/10
Catheter Precision (VTAK) reported strong 2025 financial results with 95% YoY revenue growth to $819
Mar 31, 2026
NEUTRAL
3/10
Catheter Precision, Inc. (VTAK) announced that its LockeT suture retention device will be featured i
Mar 6, 2026
Historical analyst distribution: 86% buy across 7 analysts — 3 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2025-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Aug 1, 2025 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Jul 1, 2025 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Jun 1, 2025 | 3 | 3 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 8, 2026
announcement
Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)
VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Pl
May 21, 2026
announcement
FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND
<p><i>Company Deploys Scalable Short-Haul Model into Peak Travel Window as Millions Exit NYC Metro</i></p>
May 12, 2026
earnings_calendar
VTAK Q1 2026 Earnings Scheduled — 2026-05-12
May 4, 2026
announcement
Flyte Increases Capacity and Launches Hiring Initiative as Spirit Airlines Shutdown Disrupts U.S. Air Travel
Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals <pre
Apr 21, 2026
announcement
Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy
USPTO Validates Catheter Precision’s LockeT Technology with Key Patent Allowance, Reinforcing Competitive Dominance, Long-Term Value Creation and Stre
Apr 20, 2026
announcement
FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES
<p><i>Major Carriers Accelerate Route Cuts as Economics Break Down, Creating Multi-Billion-Dollar Opportunity in Regional Air Mobility</i></p>
Apr 9, 2026
short_volume
Short Volume: VTAK — 60.8% short (0.7M / 1.1M)
Short: 681,363 | Exempt: 1,893 | TRF Vol: 1,120,370 | Short Ratio: 60.8% | Off-exchange volume (dark pool + OTC)
Apr 8, 2026
announcement
Catheter Precision to Attend the Annual European Heart Rhythm Association Conference
<p><strong>FORT MILL, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- </strong>Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) tod
Apr 6, 2026
announcement
New LockeT Data Accepted in Leading Electrophysiology Journal
<p><strong>FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) -- </strong> Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) to
Mar 31, 2026
earnings
Catheter Precision Reports 2025 Results and Updates on Strategic Expansion
<p><em>Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Ov
Mar 19, 2026
earnings_calendar
VTAK Q4 2025 Earnings After Market Close — 2026-03-19
Mar 11, 2026
short_interest
FTD: VTAK — 354,011 shares ($0.6M) failed to deliver
Settlement: 20260311, Price: $1.72, FTD Value: $608,898.92, CATHETER PRECISION INC COM PAR
Mar 6, 2026
announcement
Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026
<p><strong>FORT MILL, S.C., March 06, 2026 (GLOBE NEWSWIRE) -- </strong> Catheter Precision, Inc. (NYSE American: VTAK), a pioneer in medical techno